← Research linesL9
NAD+ and ovarian function
The 2025-2026 frontier. NAD+ decline, SIRT1/SIRT3/SIRT6, NMN vs NR, and mitochondrial quality in oocytes.
Subtopics
- 9.1NAD+ decline and ovarian aging
- 9.2SIRT6 and DNA repair in oocytes
- 9.3NMN vs NR: bioavailability and clinical evidence
- 9.4CD38 as an NAD+ siphon
- 9.5NAD+ and mitochondria in granulosa cells
- 9.6NAD+ precursors in foods vs supplements